Progression of ocular sulfur mustard injury: Development of a model system

Annals of the New York Academy of Sciences

Volumn 1194, Issue , 2010, Pages 72-80

  Milhorn, Denise ^a   Hamilton, Tracey ^b   Nelson, Marian ^b   McNutt, Patrick ^b  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Rabbit ocular injury; Sulfur mustard; Thymosin 4

Indexed keywords

MUSTARD GAS; THYMOSIN BETA4;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; EYE INJURY; INFLAMMATION; INJURY SCALE; NONHUMAN; RABBIT; ULTRASTRUCTURE;

ORYCTOLAGUS CUNICULUS;

EID: 77951772365     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05491.x     Document Type: Conference Paper

References (26)

1. Papirmeister, B., A.J. Feister, S.I. Robinson & R.D. Ford. 1991.MedicalDefense againstMustardGas: ToxicMechanisms and Pharmacological Implications.CRCPress. Boca Raton, FL.
2. Pickard, H.L. 1919. Ocular action of dichlorethylsulphide (mustard gas). Am. J. Ophthamol. 3: 136-137.
3. Badamchian,M., A.A.Damavandy, H.Damavandy, et al. 2007. Identification and quantification of thymosin beta 4 in human saliva and tears. Ann. N.Y. Acad. Sci. 1112: 458-465.
4. Balali-Mood,M. & M. Hefazi. 2005. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam. Clin. Pharmacol. 19: 297-315.
5. Mandel, M. & W.S. Gibson. 1917. Clinical manifestations and treatment of gas poisoning. JAMALXIX: 1970-1971.
6. Gates, M. & S.Moore. 1946.Mustard Gas and Other Sulphur Mustards. In Summary Technical Report of Division 9, Vol.1, Parts I,II. Office of the Scientific Research and Development.Washington, DC, pp. 30-58.
7. Mann, I. & B.D. Pullinger. 1944. A study of mustard gas lesions of the eyes of rabbits and men. Proc. R. Soc.Med. 35: 229-244.
8. Javadi, M.A., S. Yazdani, H. Sajjadi, et al. 2005. Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 112: 617-625. (Pubitemid 41108862)
9. Solberg, Y.,M. Alcalay & M. Belkin. 1997. Ocular injury by mustard gas. Surv. Ophthalmol. 41: 461-466.
10. Balali-Mood,M.&M.Hefazi. 2006.Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin. Pharmacol. Toxicol. 99: 273-282.
11. Kadar, T., S. Dachir, L. Cohen, et al. 2009. Ocular injuries following sulfur mustard exposure-pathological mechanism and potential therapy. Toxicology 263: 59-69.
12. Javadi, M.A. & M. Kazemi-Moghadam. 2000. Ocular effects of sulfer mustard poisoning. In Prevention and Treatment of Complications of Chemical Warfare Agents, A.M.Cheraghali, Ed.ChemicalWarfareResearchCenter, Tehran, Iran, pp. 82-101.
13. Blodi, F.C. 1971. Mustard gas keratopathy. Int. Ophthalmol. Clin. 11: 1-13.
14. Babin, M., K.M. Ricketts, M. Gazaway, et al. 2004. A combination treatment for ocular sulfur mustard injury in the rabbit model. Cutan. Ocul. Toxicol. 23: 65-75.
15. Sosne, G., C.C. Chan, K. Thai, et al. 2001. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72: 605-608.
16. Sosne, G., E.A. Szliter, R. Barrett, et al. 2002. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp. Eye Res. 74: 293-299.
17. Sosne, G., P.L. Christopherson, R.P. Barrett & R. Fridman. 2005. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest. Ophthalmol. Vis. Sci. 46: 2388-2395.
18. Sosne, G., P. Qiu & M. Kurpakus-Wheater. 2007. Thymosin beta-4 and the eye: I can see clearly now the pain is gone. Ann. N.Y. Acad. Sci. 1112: 114-122.
19. Mann, I. & B.D. Pullinger. 1942. A study of mustard gas lesions of the eyes of rabbits and men. Proc. R. Soc.Med. 35: 229-244.
20. Prasad, G.K., B. Singh, M.V. Suryanarayana & B.S. Batra. 2005. Kinetics of degradation of sulphur mustard on impregnated carbons. J. Hazard Mater. 121: 159-165.
21. Noort, D., A. Fidder, C.E. Degenhardt-Langelaan & A.G. Hulst. 2008. Retrospective detection of sulfur mustard exposure by mass spectrometric analysis of adducts to albumin and hemoglobin: an in vivo study. J. Anal. Toxicol. 32: 25-30.
22. Friend, J. & R.A. Thoft. 1978. Functional competence of regenerating ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 17: 134-139.
23. Sosne, G., S. Hafeez, A.L. Greenberry II &M. Kurpakus- Wheater. 2002. Thymosin beta4 promotes human conjunctival epithelial cell migration. Curr. Eye Res. 24: 268-273.
24. Sosne, G., P. Qiu & M. Kurpakus-Wheater. 2007. Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent. Clin. Ophthalmol. 1: 201-207.
25. Yarmola, E.G., E.S. Klimenko, G. Fujita & M.R. Bubb. 2007. Thymosin beta4: actin regulation and more. Ann. N.Y. Acad. Sci. 1112: 76-85.
26. Sosne, G., P. Qiu, P.L. Christopherson & M.K. Wheater. 2007. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp. Eye Res. 84: 663-669.